메뉴 건너뛰기




Volumn 34, Issue 11, 2000, Pages 1336-1340

Spironolactone in the treatment of congestive heart failure

Author keywords

Aldosterone; Heart failure; Spironolactone

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PLACEBO; SPIRONOLACTONE;

EID: 0033766352     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.10104     Document Type: Article
Times cited : (6)

References (20)
  • 2
    • 0025770664 scopus 로고
    • Pathological hypertrophy and cardiac interstitium: Fibrosis and renin-angiotensin-aldosterone system
    • (1991) Circulation , vol.83 , pp. 1849-1865
    • Weber, K.T.1    Brilla, C.G.2
  • 3
    • 0028046422 scopus 로고
    • Chronic administration of aldosterone depresses baroreceptor reflex function in the dog
    • (1994) Hypertension , vol.24 , pp. 571-575
    • Wang, W.1
  • 5
    • 0023905695 scopus 로고
    • Neurohormonal interactions and adaptations in congestive heart failure
    • (1988) Circulation , vol.77 , pp. 721-730
    • Packer, M.1
  • 9
    • 0022878709 scopus 로고
    • Spironolactone in the management of congestive heart failure: A review
    • (1986) Clin Ther , vol.9 , pp. 63-76
    • Muller, J.1
  • 17
    • 0030587794 scopus 로고    scopus 로고
    • Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (The Randomized Aldactone Evaluation Study [RALES])
    • (1996) Am J Cardiol , vol.78 , pp. 902-907
  • 20
    • 0031051347 scopus 로고    scopus 로고
    • The effect of digoxin on mortality and morbidity in patients with heart failure
    • (1997) N Engl J Med , vol.336 , pp. 525-533


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.